1. Bascoul, S., Cannat, A., Huguet, M. F. and Serre, A. (1978) Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. Immunology, 35, 213–221.
2. Bentejac, M. C., Biron, G., Bertrand, A. and Bascoul, S. (1984) Vaccination contre la brucellose humaine. Bilan sur une période de 4 ans. Dev. Biol. Stand., 56, 531–535.
3. Bolpe, J., De Lapenta, D. F. and Garcia-Carrillo, C. (1991) Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs. Rev. Inst. Med Trop., Sao-Paulo, 33, 23–27.
4. Bosseray, N., Plommet, M. and Dubray, G. (1978) Immunogenic activity of a cell wall fraction extracted from Brucella abortus in guinea pigs. Ann. Microbiol., (Inst. Pasteur.), 129B, 571–579.
5. Bowden, R. A., Cloeckaert, A., Zygmunt, M. S. and Dubray, G. (1998) Evaluation of immunogenecity and protective activity in BALB/c mice of the 25 Kda major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli. J Med Microbiol., 47, 39–48.